BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 27073104)

  • 1. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.
    Ng CL; Siciliano G; Lee MC; de Almeida MJ; Corey VC; Bopp SE; Bertuccini L; Wittlin S; Kasdin RG; Le Bihan A; Clozel M; Winzeler EA; Alano P; Fidock DA
    Mol Microbiol; 2016 Aug; 101(3):381-93. PubMed ID: 27073104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel polymorphisms in Plasmodium falciparum ABC transporter genes are associated with major ACT antimalarial drug resistance.
    Veiga MI; Ferreira PE; Jörnhagen L; Malmberg M; Kone A; Schmidt BA; Petzold M; Björkman A; Nosten F; Gil JP
    PLoS One; 2011; 6(5):e20212. PubMed ID: 21633513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
    Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
    Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin.
    Sidhu AB; Uhlemann AC; Valderramos SG; Valderramos JC; Krishna S; Fidock DA
    J Infect Dis; 2006 Aug; 194(4):528-35. PubMed ID: 16845638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).
    Gendrot M; Wague Gueye M; Tsombeng Foguim F; Madamet M; Wade KA; Bou Kounta M; Fall M; Diawara S; Benoit N; Lo G; Bercion R; Amalvict R; Mosnier J; Fall B; Briolant S; Diatta B; Pradines B
    Acta Trop; 2019 Aug; 196():126-134. PubMed ID: 31108084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin.
    Njokah MJ; Kang'ethe JN; Kinyua J; Kariuki D; Kimani FT
    Malar J; 2016 Jul; 15(1):381. PubMed ID: 27449110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport.
    Calçada C; Silva M; Baptista V; Thathy V; Silva-Pedrosa R; Granja D; Ferreira PE; Gil JP; Fidock DA; Veiga MI
    mBio; 2020 Dec; 11(6):. PubMed ID: 33262257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatio-temporal distribution of PfMDR1 polymorphism among uncomplicated Plasmodium falciparum malaria cases along international border of north east India.
    Goomber S; Mishra N; Anvikar A; Yadav CP; Valecha N
    Infect Genet Evol; 2018 Sep; 63():285-290. PubMed ID: 29842979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
    Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
    PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
    Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
    Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.
    Chavchich M; Gerena L; Peters J; Chen N; Cheng Q; Kyle DE
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2455-64. PubMed ID: 20350946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum.
    Sidhu AB; Valderramos SG; Fidock DA
    Mol Microbiol; 2005 Aug; 57(4):913-26. PubMed ID: 16091034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies.
    Gil JP; Krishna S
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):527-543. PubMed ID: 28355493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
    Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
    Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalent pfmdr1 n86y mutant Plasmodium falciparum in Madagascar despite absence of pfcrt mutant strains.
    Rason MA; Andrianantenaina HB; Ariey F; Raveloson A; Domarle O; Randrianarivelojosia M
    Am J Trop Med Hyg; 2007 Jun; 76(6):1079-83. PubMed ID: 17556614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.